Abstract
We evaluated prospectively laboratory surveillance data from Massachusetts to investigate whether seasonal variation in invasive pneumococcal disease is associated with the proportion of penicillin susceptible isolates. The proportion of penicillin susceptible isolates associated with invasive pneumococcal disease varied by season, with proportions highest in the winter and lowest in the summer, and rates of invasive disease were highest in the autumn and winter seasons and lowest in the summer.
Keywords: invasive pneumococcal disease, seasonality, penicillin susceptibility, pediatric, clinical outcome
Invasive pneumococcal disease (IPD) exhibits seasonal variation in different geographic regions.1 Climactic factors including temperature, humidity, rainfall and windspeed have been implicated,1, 2 as well as increased indoor air pollution during cold months,3 potentially from wood-burning stoves. Host factors include an increase in asthma exacerbations during cold months, which is a known risk factor for IPD.4 In children, respiratory viral infections have correlated with increased admissions with IPD.5 Cold months have also been significantly associated with higher antimicrobial resistance rates among Jewish children with acute otitis media.6 We hypothesized that seasonal variation in IPD in children would also be associated with differences in penicillin susceptibility rates, with higher nonsusceptibility rates in the winter season.
Methods
Enhanced statewide surveillance for IPD has been in place in Massachusetts since 2001, and Streptococcus pneumoniae isolates recovered from sterile sites from children less than 18 years of age are provided by clinical laboratories to the Massachusetts Department of Public Health. We analyzed Massachusetts public health surveillance of clinical laboratory reports from 2007-2012 for all children ≤5 years of age, and compared patient demographics, clinical and microbiologic features, comorbidities and other risk factors. This encompassed the period before introduction of the 13-valent pneumococcal conjugate vaccine (pre-PCV13: 2007-2009) and after (post-PCV13: 2010-2012). IPD was defined as a positive culture for S. pneumoniae from a normally sterile site. We defined the seasons as: winter (January through March), spring (April through June), summer (July through September), and autumn (October through December). For statistical analysis, we used chi-squared test of proportions to compare incidence across months and seasons, Fisher's Exact test to compare penicillin susceptibility across seasons, and to compare patient characteristics. Statistical analyses were performed using SAS v. 9.3 (SAS Institute, Cary, NC), with significance set at 5%. This study was approved by the Institutional Review Boards of the University of Minnesota and the Massachusetts Department of Public Health.
Results
Between 2007-2012, 253 cases of IPD in Massachusetts children ≤ 5 years of age were documented. Penicillin susceptibility data was available for 94.5% of isolates. There was significant variation in IPD cases overall by month and by season, with autumn and winter having higher than average incidence and summer having a much lower than average incidence (p<0.01; Figure 1). A significant association between season and number of IPD cases was noted both pre-PCV13 (p<0.01) and post-PCV13 (p=0.02). The highest incidence occurred in December (p<0.01). There was no significant association between seasonality and age (p=0.33) nor by vaccine serotype (p=0.92). Penicillin nonsusceptibility was highest in the winter (15.8%) and lowest in the summer (9.1%), but the difference was overall not significant (p=0.86), neither for pre-PCV13 (p=0.98) nor post-PCV13 periods (p=0.31).
Figure 1.
Seasonal variation in proportion of penicillin nonsusceptible isolates and relative deviation from mean number of cases of invasive pneumococcal disease
Discussion
The higher proportion of nonsusceptible isolates in the winter compared to the summer, although not statistically significant, is of interest. One possible explanation for the observed greater proportion of nonsusceptible isolates in the winter is the selective pressure from increased antimicrobial usage during cold months on pneumococcal carriage prevalence and density.6, 7 Seasonal prescribing practices for otitis media in one community setting was significantly associated with seasonality in antimicrobial susceptibility; in another community where prescription practices did not vary substantially between seasons changes in susceptibility during winter season was not observed.6
Our analysis was based solely on penicillin susceptibility, for which we had the most complete data, rather than including other antimicrobials. As a result, since cephalosporins and azithromycin have been purported to promote the carriage and spread of nonsusceptible S. pneumoniae based on their pharmacokinetic and pharmacodynamic characteristics,8 we likely have an incomplete picture of seasonal variation among antimicrobials in IPD.
In conclusion, our study shows a seasonal pattern of IPD that is largely unchanged after introduction of PCV13. This is consistent with the overall seasonal carriage pattern found in children studied following the introduction of PCV13 in Massachusetts children less than 5 years of age.9 Seasonal variation in penicillin susceptibility was also noted, although this did not reach statistical significance. Our findings suggest that seasonal variation in IPD persists and likely reflects the increased antimicrobial prescribing associated with respiratory tract infection in winter. Efforts to optimize judicious use of antimicrobials remain necessary to further reduce the prevalence of nonsusceptible pneumococci in the community.
Acknowledgements
We thank the Massachusetts Department of Public Health laboratory and epidemiology staff for their work in compiling data for this study. We thank Philippe Gaillaird for assistance with statistical analysis. PI received grant support from Pfizer [WS2420842] for this study. SIP has received honoraria for advisory board service on pneumococcal vaccines from GSK bio and Pfizer, and has received investigator-initiated grants from Pfizer and Merck. Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114.
Footnotes
Conflicts of interest: The other authors have no conflicts of interest or funding to disclose.
References
- 1.Watson M, Gilmour R, Menzies R, Ferson M, McIntyre P. The association of respiratory viruses, temperature, and other climatic parameters with the incidence of invasive pneumococcal disease in Sydney, Australia. Clin Infect Dis. 2006;42(2):211–215. doi: 10.1086/498897. [DOI] [PubMed] [Google Scholar]
- 2.Kim PE, Musher DM, Glezen WP, Rodriguez-Barradas MC, Nahm WK, Wright CE. Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis. 1996;22(1):100–106. doi: 10.1093/clinids/22.1.100. [DOI] [PubMed] [Google Scholar]
- 3.Murdoch DR, Jennings LC. Association of respiratory virus activity and environmental factors with the incidence of invasive pneumococcal disease. The Journal of infection. 2009;58(1):37–46. doi: 10.1016/j.jinf.2008.10.011. [DOI] [PubMed] [Google Scholar]
- 4.Talbot TR, Hartert TV, Mitchel E, Halasa NB, Arbogast PG, Poehling KA, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med. 2005;352(20):2082–2090. doi: 10.1056/NEJMoa044113. [DOI] [PubMed] [Google Scholar]
- 5.Ampofo K, Bender J, Sheng X, Korgenski K, Daly J, Pavia AT, et al. Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics. 2008;122(2):229–237. doi: 10.1542/peds.2007-3192. [DOI] [PubMed] [Google Scholar]
- 6.Dagan R, Barkai G, Givon-Lavi N, Sharf AZ, Vardy D, Cohen T, et al. Seasonality of antibiotic-resistant streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy? J Infect Dis. 2008;197(8):1094–1102. doi: 10.1086/528995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Weinberger DM, Grant LR, Steiner CA, Weatherholtz R, Santosham M, Viboud C, et al. Seasonal drivers of pneumococcal disease incidence: impact of bacterial carriage and viral activity. Clin Infect Dis. 2014;58(2):188–194. doi: 10.1093/cid/cit721. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.McCormick AW, Whitney CG, Farley MM, Lynfield R, Harrison LH, Bennett NM, et al. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nature medicine. 2003;9(4):424–430. doi: 10.1038/nm839. [DOI] [PubMed] [Google Scholar]
- 9.Loughlin AM, Hsu K, Silverio AL, Marchant CD, Pelton SI. Direct and indirect effects of PCV13 on nasopharyngeal carriage of PCV13 unique pneumococcal serotypes in Massachusetts' children. Pediatr Infect Dis J. 2014;33(5):504–510. doi: 10.1097/INF.0000000000000279. [DOI] [PubMed] [Google Scholar]

